- Home
- WINT vs APDN Comparison
WINT vs APDN Comparison
Compare WINT & APDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WINT
- APDN
- Stock Information
- Founded
- WINT 1992
- APDN 1983
- Country
- WINT United States
- APDN United States
- Employees
- WINT N/A
- APDN N/A
- Industry
- WINT Biotechnology: Biological Products (No Diagnostic Substances)
- APDN Other Consumer Services
- Sector
- WINT Health Care
- APDN Consumer Discretionary
- Exchange
- WINT Nasdaq
- APDN Nasdaq
- Market Cap
- WINT 2.2M
- APDN 2.0M
- IPO Year
- WINT 1995
- APDN N/A
- Fundamental
- Price
- WINT $0.14
- APDN $3.40
- Analyst Decision
- WINT Hold
- APDN
- Analyst Count
- WINT 1
- APDN 0
- Target Price
- WINT $350.00
- APDN N/A
- AVG Volume (30 Days)
- WINT 5.2M
- APDN 76.9K
- Earning Date
- WINT 08-26-2025
- APDN 08-26-2025
- Dividend Yield
- WINT N/A
- APDN N/A
- EPS Growth
- WINT N/A
- APDN N/A
- EPS
- WINT N/A
- APDN 211.51
- Revenue
- WINT N/A
- APDN $3,743,063.00
- Revenue This Year
- WINT N/A
- APDN $57.08
- Revenue Next Year
- WINT N/A
- APDN $40.00
- P/E Ratio
- WINT N/A
- APDN $0.02
- Revenue Growth
- WINT N/A
- APDN 55.60
- 52 Week Low
- WINT $0.10
- APDN $3.20
- 52 Week High
- WINT $662.00
- APDN $2,655.00
- Technical
- Relative Strength Index (RSI)
- WINT 24.01
- APDN 31.55
- Support Level
- WINT $0.45
- APDN $3.20
- Resistance Level
- WINT $0.51
- APDN $4.64
- Average True Range (ATR)
- WINT 0.08
- APDN 0.30
- MACD
- WINT -0.05
- APDN -0.04
- Stochastic Oscillator
- WINT 8.93
- APDN 13.89
About WINT Windtree Therapeutics Inc.
Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.
About APDN Applied DNA Sciences Inc.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.